21 CFR §26.32

1. (a)The provisions of this subpart shall apply to the exchange and, where appropriate, endorsement of the following types of reports from conformity assessment bodies (CAB's) assessed to be equivalent:
   1. (1)Under the U.S. system, surveillance/postmarket and initial/preapproval inspection reports;
   2. (2)Under the U.S. system, premarket (510(k)) product evaluation reports;
   3. (3)Under the European Community (EC) system, quality system evaluation reports; and
   4. (4)Under the EC system, EC type examination and verification reports.
2. (b)Appendix A of this subpart names the legislation, regulations, and related procedures under which:
   1. (1)Products are regulated as medical devices by each party;
   2. (2)CAB's are designated and confirmed; and
   3. (3)These reports are prepared.
3. (c)For purposes of this subpart, equivalence means that: CAB's in the EC are capable of conducting product and quality systems evaluations against U.S. regulatory requirements in a manner equivalent to those conducted by FDA; and CAB's in the United States are capable of conducting product and quality systems evaluations against EC regulatory requirements in a manner equivalent to those conducted by EC CAB's.